MedCity News January 27, 2025
Arundhati Parmar

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question?

The U.S. stock market, especially the tech-heavy NASDAQ, was deeply (no pun intended) rattled by a Chinese AI upstart called DeepSeek on Monday. It appears to have accomplished much of what large language models developed in the U.S. have but at a fraction of the cost and with lower-grade technology. Remember how the U.S. restricts the sale of advanced microchips to China citing security reasons.

The DeepSeek R1 model is breaking the internet, apparently.

So here at MedCity News, we decided to do a head-to-head test with DeepSeek and ChatGPT...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Conferences / Podcast, Technology, Trends
Cerebras And Mayo Clinic To Debut Genomic Tool
Outsmarting AI-powered cyber attacks: A 2025 playbook for real-time endpoint defense
Essential principles to produce and consume data for AI acceleration
Alibaba’s Qwen2.5-Max challenges U.S. tech giants, reshapes enterprise AI
Use a military approach to get C-suite buy-in for AI, says one physician

Share This Article